|
ZNF507 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.37940025857608E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.63499999597627E-09 |
| Normal-vs-Stage2 |
7.67600000228796E-08 |
| Normal-vs-Stage3 |
1.4570000761438E-10 |
| Normal-vs-Stage4 |
8.09340372498468E-11 |
| Stage1-vs-Stage2 |
9.517400E-01 |
| Stage1-vs-Stage3 |
1.376780E-01 |
| Stage1-vs-Stage4 |
5.748000E-02 |
| Stage2-vs-Stage3 |
3.433800E-01 |
| Stage2-vs-Stage4 |
1.903020E-01 |
| Stage3-vs-Stage4 |
5.687400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85079967912816E-10 |
| Normal-vs-AfricanAmerican |
7.952500E-04 |
| Normal-vs-Asian |
1.43830000132183E-08 |
| Caucasian-vs-AfricanAmerican |
1.167200E-01 |
| Caucasian-vs-Asian |
7.775400E-01 |
| AfricanAmerican-vs-Asian |
1.927360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.43429984240151E-10 |
| Normal-vs-Female |
7.51089967998553E-10 |
| Male-vs-Female |
7.653200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.18430001758452E-09 |
| Normal-vs-Age(41-60Yrs) |
5.02070052199599E-10 |
| Normal-vs-Age(61-80Yrs) |
1.15629994468236E-09 |
| Normal-vs-Age(81-100Yrs) |
1.356810E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.958200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.146800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.541000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.181000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.525600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.777400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.136750E-03 |
| Classical-VS-Follicular |
7.086000E-01 |
| Classical-VS-Other |
3.487200E-01 |
| Classical-VS-Normal |
9.97060001228789E-09 |
| Tall-VS-Follicular |
2.477500E-02 |
| Tall-VS-Other |
6.702200E-01 |
| Tall-VS-Normal |
1.58819624118678E-11 |
| Follicular-VS-Other |
5.345800E-01 |
| Follicular-VS-Normal |
5.41970002210235E-09 |
| Other-VS-Normal |
2.655600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.02369948260662E-10 |
| Normal-vs-N1 |
2.10249995191703E-09 |
| N0-vs-N1 |
5.146400E-01 |
|
|
